Double-Blind, Crossover, Placebo-Controlled Evaluation of the Effect of Levalbuterol (R-Albuterol) [levosalbutamol] on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma.

Trial Profile

Double-Blind, Crossover, Placebo-Controlled Evaluation of the Effect of Levalbuterol (R-Albuterol) [levosalbutamol] on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2011

At a glance

  • Drugs Levosalbutamol; S-salbutamol
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Mar 2011 Actual end date changed from Nov 2008 to Nov 2009 as reported by ClinicalTrials.gov.
    • 07 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top